{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:52:03Z","timestamp":1782741123513,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40120-022-00393-1","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T08:08:25Z","timestamp":1660291705000},"page":"1609-1623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-3192","authenticated-orcid":false,"given":"Amir Abbas","family":"Tahami Monfared","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tafazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameya","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Deger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"A Association","year":"2021","unstructured":"Association A. 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2021;17:327\u2013406.","journal-title":"Alzheimers Dement"},{"key":"393_CR2","unstructured":"National Alzheimer\u2019s Project Act (NAPA). Draft national plan to address Alzheimer\u2019s disease. https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/66904c18bb1f0843c3c113d7099e98c1\/napa-national-plan-2021-update.pdf. Accessed 2 June 2021."},{"issue":"1","key":"393_CR3","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement (N Y). 2021;7(1):e12179.","journal-title":"Alzheimers Dement (N Y)"},{"key":"393_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1462","volume":"373","author":"E Mahase","year":"2021","unstructured":"Mahase E. FDA approves controversial Alzheimer\u2019s drug despite uncertainty over effectiveness. BMJ. 2021;373:n1462.","journal-title":"BMJ"},{"key":"393_CR5","unstructured":"Alzheimer\u2019s disease neuroimaging initiative. Home page 2017. http:\/\/adni.loni.usc.edu\/. Accessed 2 June 2021."},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trci.2018.01.001","volume":"4","author":"AR Kansal","year":"2018","unstructured":"Kansal AR, Tafazzoli A, Ishak KJ, Krotneva S. Alzheimer\u2019s disease archimedes condition-event simulator: development and validation. Alzheimers Dement (N Y). 2018;4:76\u201388.","journal-title":"Alzheimers Dement (N Y)"},{"key":"393_CR7","unstructured":"Tafazzoli A, Weng J, Sutton K, et al., editors. Validating simulated cognition trajectories based on ADNI against trajectories from the National Alzheimer\u2019s Coordinating Center (NACC) dataset. In: 11th Clinical Trial on Alzheimer\u2019s Disease (CTAD); 2018; Barcelona, Spain."},{"issue":"5","key":"393_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2165\/11531870-000000000-00000","volume":"28","author":"D Getsios","year":"2010","unstructured":"Getsios D, Blume S, Ishak KJ, Maclaine GD. Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer\u2019s disease: a UK evaluation using discrete-event simulation. Pharmacoeconomics. 2010;28(5):411\u201327.","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"393_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40273-014-0203-5","volume":"32","author":"S Guo","year":"2014","unstructured":"Guo S, Getsios D, Revankar N, et al. Evaluating disease-modifying agents: a simulation framework for Alzheimer\u2019s disease. Pharmacoeconomics. 2014;32(11):1129\u201339.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"393_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1532-5415.2002.50065.x","volume":"50","author":"GW Small","year":"2002","unstructured":"Small GW, McDonnell DD, Brooks RL, Papadopoulos G. The impact of symptom severity on the cost of Alzheimer\u2019s disease. J Am Geriatr Soc. 2002;50(2):321\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"393_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40120-022-00350-y","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, Tafazzoli A, Ye W, Chavan A, Zhang Q. Long-term health outcomes of lecanemab in patients with early Alzheimer\u2019s disease using simulation modeling. Neurol Ther. 2022;11(2):863\u201380.","journal-title":"Neurol Ther"},{"key":"393_CR12","doi-asserted-by":"crossref","unstructured":"Tahami Monfared AA, Tafazzoli A, Chavan A, Ye W, Zhang Q. The potential economic value of lecanemab in patients with early Alzheimer's disease using simulation modeling. Neurol Ther. 2022;11(3):1285\u20131307.","DOI":"10.1007\/s40120-022-00373-5"},{"issue":"8","key":"393_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O'Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Waring SC, Cullum CM, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s Research Consortium study. Arch Neurol. 2008;65(8):1091\u20135.","journal-title":"Arch Neurol"},{"key":"393_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101339","volume":"68","author":"KI Avgerinos","year":"2021","unstructured":"Avgerinos KI, Ferrucci L, Kapogiannis D. Effects of monoclonal antibodies against amyloid-beta on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease. Ageing Res Rev. 2021;68: 101339.","journal-title":"Ageing Res Rev"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.dadm.2018.04.001","volume":"10","author":"E Fletcher","year":"2018","unstructured":"Fletcher E, Filshtein TJ, Harvey D, Renaud A, Mungas D, DeCarli C. Staging of amyloid beta, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: results of serial mediation analyses. Alzheimers Dement (Amst). 2018;10:382\u201393.","journal-title":"Alzheimers Dement (Amst)"},{"key":"393_CR16","unstructured":"Howden LM, Meyer JA. Age and sex composition: 2010: United States Census Bureau; 2011. https:\/\/www.census.gov\/prod\/cen2010\/briefs\/c2010br-03.pdf. Accessed 2 June 2021."},{"key":"393_CR17","unstructured":"United States Census Bureau. 2017 national population projections tables: main series 2017. https:\/\/www.census.gov\/data\/tables\/2017\/demo\/popproj\/2017-summary-tables.html. Accessed 2 June 2021."},{"key":"393_CR18","unstructured":"U.S. Census Bureau Population Division. Projected 5-year age groups and sex composition of the population (np2017-t3). September 2018. https:\/\/www2.census.gov\/programs-surveys\/popproj\/tables\/2017\/2017-summary-tables\/np2017-t3.xlsx. Accessed 2 June 2021."},{"issue":"11","key":"393_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142388","volume":"10","author":"PS Sachdev","year":"2015","unstructured":"Sachdev PS, Lipnicki DM, Kochan NA, et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC collaboration. PLoS ONE. 2015;10(11):e0142388.","journal-title":"PLoS ONE"},{"issue":"3","key":"393_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","volume":"90","author":"RC Petersen","year":"2018","unstructured":"Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126\u201335.","journal-title":"Neurology"},{"issue":"2","key":"393_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011146","volume":"7","author":"L Lang","year":"2017","unstructured":"Lang L, Clifford A, Wei L, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017;7(2):e011146.","journal-title":"BMJ Open"},{"issue":"8","key":"393_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/JGP.0b013e3181cdee4f","volume":"18","author":"M Ganguli","year":"2010","unstructured":"Ganguli M, Chang CC, Snitz BE, Saxton JA, Vanderbilt J, Lee CW. Prevalence of mild cognitive impairment by multiple classifications: the Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project. Am J Geriatr Psychiatry. 2010;18(8):674\u201383.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"393_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3182452862","volume":"78","author":"RO Roberts","year":"2012","unstructured":"Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology. 2012;78(5):342\u201351.","journal-title":"Neurology"},{"issue":"1","key":"393_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000265553","volume":"29","author":"K Andersen","year":"2010","unstructured":"Andersen K, Lolk A, Martinussen T, Kragh-Sorensen P. Very mild to severe dementia and mortality: a 14-year follow-up\u2014the Odense study. Dement Geriatr Cogn Disord. 2010;29(1):61\u20137.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"393_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jalz.2019.05.004","volume":"15","author":"C Green","year":"2019","unstructured":"Green C, Handels R, Gustavsson A, et al. Assessing cost-effectiveness of early intervention in Alzheimer\u2019s disease: an open-source modeling framework. Alzheimers Dement. 2019;15(10):1309\u201321.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"393_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-191212","volume":"75","author":"RL Robinson","year":"2020","unstructured":"Robinson RL, Rentz DM, Andrews JS, et al. Costs of early stage Alzheimer\u2019s disease in the United States: cross-sectional analysis of a prospective cohort study (GERAS-US)1. J Alzheimers Dis. 2020;75(2):437\u201350.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"393_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-122392","volume":"36","author":"A Wimo","year":"2013","unstructured":"Wimo A, Reed CC, Dodel R, et al. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer\u2019s disease in three European countries\u2013study design and baseline findings. J Alzheimers Dis. 2013;36(2):385\u201399.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"393_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1377\/hlthaff.17.6.206","volume":"17","author":"J Leon","year":"1998","unstructured":"Leon J, Cheng CK, Neumann PJ. Alzheimer\u2019s disease care: costs and potential savings. Health Aff (Millwood). 1998;17(6):206\u201316.","journal-title":"Health Aff (Millwood)"},{"key":"393_CR29","unstructured":"Alzeimer's Association. Trajectory report. https:\/\/www.alz.org\/help-support\/resources\/publications\/trajectory_report. Accessed 2 June 2021."},{"key":"393_CR30","unstructured":"Genworth. Cost of Care Survey 2021. https:\/\/www.genworth.com\/aging-and-you\/finances\/cost-of-care.html. Accessed 2 June 2021."},{"key":"393_CR31","unstructured":"US Bureau of Labor Statistics. 12-month percentage change, Consumer Price Index, selected categories 2021. https:\/\/www.bls.gov\/charts\/consumer-price-index\/consumer-price-index-by-category-line-chart.htm. Accessed 2 June 2021."},{"key":"393_CR32","unstructured":"Alzeimer's Association. Changing the trajectory of Alzheimer\u2019s disease: how a treatment by 2025 saves lives and dollars 2015. https:\/\/www.alz.org\/media\/Documents\/changing-the-trajectory-r.pdf. Accessed 2 June 2021."},{"key":"393_CR33","unstructured":"The Lewin Group. Saving lives, saving money: dividends for Americans from investing in Alzheimer\u2019s research 2004. http:\/\/www.lewin.com\/~\/media\/Lewin\/Site_Sections\/Publications\/2867.pdf. Accessed 2 June 2021."},{"issue":"1","key":"393_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/fhep-2014-0013","volume":"18","author":"J Zissimopoulos","year":"2014","unstructured":"Zissimopoulos J, Crimmins E, St. Clair P. The value of delaying Alzheimer\u2019s disease onset. Forum Health Econ Policy. 2014;18(1):25\u201339.","journal-title":"Forum Health Econ Policy"},{"key":"393_CR35","unstructured":"Access Economics PTY Limited. Delaying the onset of Alzeimer's disease: projections and issues 2004. https:\/\/www.dementia.org.au\/sites\/default\/files\/20040820_Nat_AE_DelayOnsetADProjIssues.pdf. Accessed 2 June 2021."},{"issue":"9","key":"393_CR36","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","volume":"88","author":"R Brookmeyer","year":"1998","unstructured":"Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer\u2019s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):1337\u201342.","journal-title":"Am J Public Health"},{"key":"393_CR37","doi-asserted-by":"crossref","unstructured":"Yuan J, Maserejian N, Liu Y, et al. Severity distribution of Alzheimer\u2019s disease dementia and mild cognitive impairment in the Framingham Heart Study. J Alzheimers Dis\n. 2021;79(2):807\u2013817.","DOI":"10.3233\/JAD-200786"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00393-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-022-00393-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00393-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:26:08Z","timestamp":1666445168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-022-00393-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s40120-022-00393-1","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}